Viewing Study NCT01902160


Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2026-03-01 @ 10:01 AM
Study NCT ID: NCT01902160
Status: COMPLETED
Last Update Posted: 2015-11-09
First Post: 2013-07-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Temsirolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module